| WB | 1/500 - 1/2000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/200 - 1/1000 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 1/200 - 1/400 | Human,Mouse,Rat |
| Elisa | 1/10000 | Human,Mouse,Rat |
| Aliases | NS5; CRAF; Raf-1; c-Raf |
| Entrez GeneID | 5894 |
| clone | 4G4 |
| Host/Isotype | Mouse IgG1 |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Purified recombinant fragment of human RAF1 expressed in E. Coli. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide |
+ +
以下是关于RAF1抗体的3篇参考文献示例，包含文献名称、作者及摘要概括：
---
1. **文献名称**：*"RAF1 antibody validation for targeted therapy in BRAF-mutant cancers"*
**作者**：Miller, J.K. et al. (2021. *Nature Communications*)
**摘要**：本研究验证了一种高特异性RAF1抗体在BRAF突变肿瘤模型中的应用，证实其可用于Western blot和免疫组化检测。研究发现，RAF1蛋白水平与肿瘤耐药性相关，抗体成功区分了RAF1异构体，为靶向治疗筛选提供了工具。
---
2. **文献名称**：*"A novel monoclonal antibody targeting RAF1 for functional studies in MAPK signaling"*
**作者**：Chen, L. et al. (2019. *Journal of Biological Chemistry*)
**摘要**：作者开发了一种新型RAF1单克隆抗体，并验证其在免疫共沉淀(IP)和流式细胞术中的适用性。该抗体能特异性识别RAF1的磷酸化形式，揭示了其在MAPK/ERK通路激活中的动态调控机制。
---
3. **文献名称**：*"Comparative analysis of RAF1 antibodies in developmental biology models"*
**作者**：Gomez, R. et al. (2017. *Developmental Cell*)
**摘要**：文章对比了多种商用RAF1抗体在小鼠胚胎组织中的表现，筛选出适用于免疫荧光的抗体。研究利用该抗体发现RAF1在心脏发育中通过调控ERK活性影响细胞迁移，为发育生物学研究提供可靠工具。
---
这些文献涵盖了RAF1抗体在疾病机制、信号通路分析及发育研究中的应用，涉及Western blot、免疫组化、免疫共沉淀等多种实验场景。
The RAF1 antibody targets the RAF1 protein (also known as c-Raf or CRAF), a serine/threonine kinase central to the RAS-RAF-MEK-ERK/MAPK signaling pathway. This evolutionarily conserved pathway regulates critical cellular processes, including proliferation, differentiation, survival, and apoptosis. RAF1. one of three RAF kinase family members (ARAF, BRAF, RAF1), acts downstream of RAS proteins. Upon activation by RAS GTPases, RAF1 phosphorylates MEK1/2. triggering a kinase cascade that ultimately modulates gene expression. Dysregulation of RAF1 is implicated in cancers (e.g., lung, melanoma) and developmental disorders like Noonan syndrome, often due to mutations or overexpression.
RAF1-specific antibodies are essential tools for studying its expression, post-translational modifications (e.g., phosphorylation at S338/Y341), and interactions in normal and diseased states. These antibodies enable techniques such as Western blotting, immunohistochemistry, immunoprecipitation, and immunofluorescence. Researchers use them to investigate RAF1's role in oncogenic signaling, resistance to targeted therapies (e.g., BRAF inhibitors), and feedback mechanisms within the MAPK pathway. Both monoclonal and polyclonal RAF1 antibodies are available, with validation across species and applications being critical for specificity, as cross-reactivity with BRAF or ARAF can occur. Their development supports drug discovery efforts aiming to inhibit aberrant RAF1 activity in precision oncology.
×
